Clinical ResearchPeripheralImmediate Outcomes of Covered Stent Placement for Treatment or Prevention of Aortic Wall Injury Associated With Coarctation of the Aorta (COAST II)
Peripheral
Under an Elsevier user license
open archive
Key Words
aortic aneurysm
aortic coarctation
congenital heart disease
endoleak
stent
thoracic
Abbreviations and Acronyms
AE
adverse event(s)
AWI
aortic wall injury
CP
Cheatham-Platinum (stent)
CCPS
Covered Cheatham-Platinum stent
CoA
coarctation of the aorta
CT
computed tomography
FDA
Food and Drug Administration
SBP
systolic blood pressure
Cited by (0)
Support for the COAST II study is provided by a grant from the FDA Office of Orphan Product Development, grant number: 1R01FD003898-01. The NuMED Corp., maker of the Covered CP stent and Balloon-in-Balloon catheters, provided funding for this trial, including salary and administrative support for Mr. Minahan, Ms. Usmani, and Dr. Ringel. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.